Rani Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Rani Therapeutics's estimated annual revenue is currently $19.1M per year.
- Rani Therapeutics's estimated revenue per employee is $155,000
- Rani Therapeutics's total funding is $211.5M.
Employee Data
- Rani Therapeutics has 123 Employees.
- Rani Therapeutics grew their employee count by -10% last year.
Rani Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and Executive Chairman | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | General Counsel | Reveal Email/Phone |
4 | Controller | Reveal Email/Phone |
5 | VP Quality Assurance | Reveal Email/Phone |
6 | General Counsel | Reveal Email/Phone |
7 | VP, Medical Affairs | Reveal Email/Phone |
8 | VP, Clinical Development | Reveal Email/Phone |
9 | Chief Financial Officer | Reveal Email/Phone |
10 | Director Clinical Operations | Reveal Email/Phone |
Rani Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Rani Therapeutics?
Rani Therapeutics has developed the RaniPillâ„¢, a platform technology for the oral delivery of biologic drugs. Millions of patients with chronic conditions require biologic drugs that today can only be injected. These injections are painful and inconvenient and often affect both patient compliance and quality of life. The pharma industry has been searching for decades to convert injectables into pills, and we believe the solution is the RaniPillâ„¢ capsule. We have demonstrated bioavailability similar to subcutaneous injections in both preclinical and clinical studies. Rani has an internal pipeline of molecules, and active collaborations with Novartis and Takeda. The research and technology behind Rani Therapeutics came out of InCube Labs, a multi-disciplinary life sciences R&D lab focused on breakthrough medical innovations. InCube is led by Mir Imran, a prolific medical inventor, entrepreneur, and investor.
keywords:N/A
$211.5M
Total Funding
123
Number of Employees
$19.1M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Rani Therapeutics News
RANI THERAPEUTICS HOLDINGS, INC. 2051 Ringwood Avenue. San Jose, California 95131. PROXY STATEMENT. FOR THE 2022 ANNUAL MEETING OF STOCKHOLDERS.
Rani Therapeutics is a clinical stage biotherapeutics company focused on advancing technologies to enable the development of orally administered...
Rani Therapeutics is a clinical stage biotherapeutics company focused on advancing technologies to enable the development of orally administered...
Rani Therapeutics, a San Jose-based company developing a pill to replace medical injections, went public on Friday. According to S-1 filings, shares were estimated to price between $14 and $16 last week. On Friday, shares debuted slightly lower, around $11. Rani raised about $73 million in its ...
A new auto-injecting pill might soon become a replacement for subcutaneous injection treatments. The idea for this so-called robotic pill came out of a research project around eight years ago from InCube Labs — a life sciences lab operated by Rani Therapeutics Chairman and CEO Mir Imran, who ha ...
Other Companies in San Jose
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 124 | -23% | N/A |
#2 | $36M | 124 | 4% | N/A |
#3 | $15M | 124 | -5% | N/A |
#4 | $37.2M | 124 | -1% | N/A |
#5 | $43.8M | 125 | 8% | $454.9M |